Technology-Driven CRO Crystal Pharmatech Expands Solid State Research Provider Services with VXP Pharma
North Brunswick, NJ (PRWEB) March 06, 2014 -- Crystal Pharmatech will give its leading solid state research capabilities in the US an additional boost this month with a new partnership agreement with VxP Pharma, the company announced this month. VxP Pharma operates as a full service CRO/CMO and offers drug development services from Discovery through Phase IIb by contracting with specialist facilities, labs and manufacturing sites worldwide to accomplish different areas of drug development. Crystal Pharmatech, a global solid state research lab company with labs in Suzhou, China and North Brunswick, NJ, has gained respect in the pharmaceutical industry as a preferred provider based on its founding principles and a skill set that is seamlessly aligned with those of top pharmaceutical companies.
"The basis of this partnership between Crystal Pharmatech and VxP Pharma is the fact that VxP Pharma has done its due-diligence by thoroughly vetting specialized CRO's and CMO's and, as a result, VxP can offer the highest level of service in any development area. Our company has the scientific rigor to be the preferred solid state research provider for VxP Pharma's suite of specialized CRO's," explained Dr. Robert Wenslow, PhD, VP Business Development at Crystal Pharmatech.
As the scientific complexity of chemical development increases, finding the optimal development path for both drug substance (API) and drug product (formulation) is of utmost importance. This demands a fundamental understanding of the materials science surrounding the API and formulations. Crystal Pharmatech is an expert in polymorphs, co-crystals, salts, analytical methods and crystallization development. "If you want to get a molecule into the clinic, it is essential to understand the solid state properties of both your API and your formulation and we feel that Crystal Pharmatech is the best organization to ensure your success in this endeavor," stated Ray Peck, CEO, VxP Pharma. He added, "Crystal Pharmatech has extensive, multi-layered IP protection in place, as well as FDA standards in place at all levels, which is a top priority for both VxP and our customers.” http://www.vxppharma.com
Crystal Pharmatech is a technology-driven CRO whose services range from solid state information to processing for active pharmaceutical ingredients and formulations. Crystal Pharmatech provides clients with data derived from experiments and partners with clients to ensure comprehensive solutions for their research needs based on sound scientific understanding.
http://www.crystalpharmatech.com
https://twitter.com/CrystalPharma
http://linkd.in/1cvaxNc
Isabelle Kellogg, Kellogg & Partners, +1 917 361 2866, [email protected]
Share this article